此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Risk of Cervical Cancer Following Incident, Persistent and History-unknown HPV Detection

2026年9月24日 更新者:Jiangrong Wang、Karolinska Institutet

Risk of Cervical Cancer Following Incident, Persistent and History-unknown Human Papillomavirus (HPV) Detection by HPV Genotype

The goal of this register-based retrospective observational study is to understand the risk of cervical cancer following incident, persistent and history-unknown HPV detection by HPV genotype in healthy women participating in HPV-based cervical screening. The main questions it aims to answer are:

  1. Whether an incident HPV detection with certain HPV genotypes has low risk of cervical cancer in 3 to 5 years thus does not need further clinical assessment before the next screening test?
  2. How risky a persistent HPV detection is, and whether persistent detection of any high-risk HPV genotype warrant immediate clinical assessment?
  3. How risky a HPV detection is, if no previous HPV test result is available?

As being a register-based retrospective observational study, study subjects will not be asked to do any specific task for this study.

研究概览

详细说明

This study includes all women in the study population (women at screening ages and living in the Stockholm region during 2014-2023) who had HPV positive test result(s) in the primary HPV screening. In 2014-2016, half of the screening population were randomised to primary HPV screening and the other half received cytology-based screening (NCT01511328). From 2017 onwards, all women received primary HPV screening. As data are retrieved from established registries which are already accessible to the researchers for previous and ongoing related research projects, the data collection time is almost negligible.

研究类型

观察性的

注册 (估计的)

130000

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

研究联系人备份

学习地点

      • Stockholm、瑞典、141 52
        • 招聘中
        • Centre for Cervical Cancer Elimination, Department of Clinical Science, Intervention and Technology, Karolinska Institutet
        • 接触:
        • 接触:
        • 副研究员:
          • Jiangrong Wang, PhD
        • 首席研究员:
          • Joakim Dillner, PhD

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

22年 至 70年 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

女性

取样方法

概率样本

研究人群

Women living in the Great Stockholm Region in Sweden, at cervical screening ages (age 22-70 years), and having had an HPV positive result in the primary HPV test during 2014-2023

描述

Inclusion Criteria:

  • Women living in the Great Stockholm Region in Sweden, at cervical screening ages (age 22-70 years), and having had an HPV positive result in primary HPV test during 2014-2023

Exclusion Criteria:

  • Women without valid personal identity number in the population registry

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 观测模型:COHORT
  • 时间观点:RETROSPECTIVE

队列和干预

团体/队列
干预/治疗
Incident HPV detection

The first HPV positive result in the primary HPV test, following an HPV negative test result in the previous primary HPV test

All data will be retrieved retrospectively from registry data.

Persistent HPV detection

The HPV positive result in the primary HPV test following an HPV positive test result with the same genotype in the previous primary HPV test

All data will be retrieved retrospectively from registry data.

History-unknown HPV detection

The first HPV positive result in the primary HPV test, without any primary HPV test record in the past

All data will be retrieved retrospectively from registry data.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Diagnosis of invasive cervical cancer
大体时间:From HPV infection to the end of the study Dec 31st, 2024

Primary and invasive cervical cancer

From HPV infection to the end of the study Dec 31st, 2024

次要结果测量

结果测量
措施说明
大体时间
Precancerous lesion CIN2+ (Cervical Intraepithelial Neoplasia grade 2 and above)
大体时间:From HPV infection to the end of the study Dec 31st, 2024

CIN2, CIN3, Adenocarcinoma in situ

From HPV infection to the end of the study Dec 31st, 2024

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2025年10月31日

初级完成 (实际的)

2025年11月3日

研究完成 (估计的)

2026年12月1日

研究注册日期

首次提交

2026年9月24日

首先提交符合 QC 标准的

2026年9月24日

首次发布 (实际的)

2026年9月30日

研究记录更新

最后更新发布 (实际的)

2026年9月30日

上次提交的符合 QC 标准的更新

2026年9月24日

最后验证

2026年9月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

是的

IPD 计划说明

IPD will be derived from the Swedish National Cervical Screening Registry and the Swedish National Quality Register for Gynaecological Cancers. Data from these two registries can be shared upon application, provided that ethical approval is obtained.

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅